跳至主要内容
临床试验/DRKS00033177
DRKS00033177尚未招募Unknown

Evaluation of a standardized therapy regimen in early rehabilitation for ICU acquired weakness - Early-CIP Study - Early-CIP

Cellitinnen Krankenhaus St. Marien0 个研究点目标入组 124 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Women and men who have developed an ICU acquired weakness after intensive care treatment and who have signed the declaration of consent. Inclusion can also take place after the signature of the legal representative in the event that the patient is temporarily unable to give consent.

排除标准

  • - pregnancy
  • - Leg amputation or other cause of inability to walk even before critical illness (crutches or walkers are no exclusion criteria)
  • - Previously known severe dementia or other cause of higher-grade cognitive deficits
  • - Other neuromuscular diseases (GBS, ALS, myasthenia gravis)
  • - Long-term steroid therapy and Cushing's disease
  • - Acute stroke
  • - Acute myocardial infarction
  • - Acute fractures, unstable cervical spine or pathological Fractures
  • - Multi-resistant germs that leave the room

研究者

发起方
Cellitinnen Krankenhaus St. Marien

相似试验